Screening and preventing prostate cancer: implementing the evidence.
Prostate cancer is the most common non-skin cancer in America, and while many benefits exist associated with routine prostate-specific antigen (PSA) screening, there is a lack of research evidence to support this behavior. This column will describe the state of the science of prostate screening outcomes and present the possible impact medications that prevent prostate cancer may have on screening activities.